59
Participants
Start Date
February 29, 2012
Primary Completion Date
November 30, 2015
Study Completion Date
February 29, 2016
Trans Sodium Crocetinate (TSC)
TSC administered intravenously as a bolus injection prior to radiation therapy sessions during 6 weeks of radiotherapy.
North Shore University Hospital, Manhasset
Penn State University Milton S. Hershey Medical Center, Hershey
The George Washington University Medical Center, Washington D.C.
UVA Health Sciences Center Emily Couric Clinical Cancer Center, Charlottesville
Forsyth Regional Cancer Center, Winston-Salem
Medical University of South Carolina, Charleston
Emory University Winship Cancer Institute, Atlanta
University of Florida McKnight Brain Institute, Gainesville
University of Kentucky Markey Cancer Center, Lexington
Froedtert & Medical College of Wisconsin Cancer Center, Milwaukee
Northwestern University Robert H. Lurie Comprehensive Cancer Center, Chicago
Rush University Medical Center, Chicago
University of Arkansas Winthrop P. Rockefeller Cancer Institute, Little Rock
Baylor University Medical Center, Dallas
University of Texas Health Science Center Memorial Hermann Medical Center, Houston
St. Joseph's Medical Center Barrow Neurology Clinics, Phoenix
USC/Norris Comprehensive Cancer Center, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
Lead Sponsor
Diffusion Pharmaceuticals Inc
INDUSTRY